Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Leverenz

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Drug Design, Development and Therapy|May 12, 2021
The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical DataBabak Tousi, James B Leverenz
Brain Pathology (Zurich, Switzerland)|June 5, 2010
Profile of cognitive impairment in Parkinson's diseaseG Stennis Watson, James B Leverenz
Handbook of Clinical Neurology|July 18, 2008
Clinical aspects of hippocampal sclerosisJames B Leverenz, Anne M Lipton
Neurodegenerative Disease Management|February 26, 2015
The biomarker and therapeutic potential of miRNA in Alzheimer's diseaseLynn M Bekris, James B Leverenz
Chest|January 15, 2017
Sleep and Neurodegeneration: A Critical AppraisalJagan A Pillai, James B Leverenz
The Medical Clinics of North America|August 13, 2002
Dementia with Lewy bodiesJames B Leverenz, Ian G McKeith
Alzheimer'S Research & Therapy|September 22, 2010
From model system to clinical medicine: pathophysiologic links of common proteinopathiesPamela J McMillan, James B Leverenz
Cleveland Clinic Journal of Medicine|September 2, 2020
Emerging blood-based biomarkers for Alzheimer diseaseLynn M Bekris, James B Leverenz
Archives of Neurology|May 13, 2009
The expanding role of genetics in the lewy body diseases: the glucocerebrosidase geneJames B Leverenz, Oscar L Lopez, Steven T Dekosky
Innovation in Aging|December 4, 2023
The Media Coverage of Bruce Willis Reveals Unfamiliarity With Frontotemporal DegenerationRobert S Hurley, Jagan A Pillai, James B Leverenz
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Drug Design, Development and Therapy|May 12, 2021
The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical DataBabak Tousi, James B Leverenz
Brain Pathology (Zurich, Switzerland)|June 5, 2010
Profile of cognitive impairment in Parkinson's diseaseG Stennis Watson, James B Leverenz
Handbook of Clinical Neurology|July 18, 2008
Clinical aspects of hippocampal sclerosisJames B Leverenz, Anne M Lipton
Neurodegenerative Disease Management|February 26, 2015
The biomarker and therapeutic potential of miRNA in Alzheimer's diseaseLynn M Bekris, James B Leverenz
Chest|January 15, 2017
Sleep and Neurodegeneration: A Critical AppraisalJagan A Pillai, James B Leverenz
The Medical Clinics of North America|August 13, 2002
Dementia with Lewy bodiesJames B Leverenz, Ian G McKeith
Alzheimer'S Research & Therapy|September 22, 2010
From model system to clinical medicine: pathophysiologic links of common proteinopathiesPamela J McMillan, James B Leverenz
Cleveland Clinic Journal of Medicine|September 2, 2020
Emerging blood-based biomarkers for Alzheimer diseaseLynn M Bekris, James B Leverenz
Archives of Neurology|May 13, 2009
The expanding role of genetics in the lewy body diseases: the glucocerebrosidase geneJames B Leverenz, Oscar L Lopez, Steven T Dekosky
Innovation in Aging|December 4, 2023
The Media Coverage of Bruce Willis Reveals Unfamiliarity With Frontotemporal DegenerationRobert S Hurley, Jagan A Pillai, James B Leverenz
Pageof 24